Manulife (Manufacturers Life Insurance)’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-3,130
Closed -$260K 3003
2025
Q2
$260K Buy
+3,130
New +$250K ﹤0.01% 2440
2020
Q3
Sell
-60,129
Closed -$6.64M 2940
2020
Q2
$6.64M Buy
60,129
+55,185
+1,116% +$5.43M 0.01% 977
2020
Q1
$383K Buy
+4,944
New +$438K ﹤0.01% 1955
2018
Q4
Sell
-19,608
Closed -$1.88M 2850
2018
Q3
$1.88M Buy
19,608
+9,219
+89% +$894K ﹤0.01% 1486
2018
Q2
$989K Sell
10,389
-11,403
-52% -$1.05M ﹤0.01% 1896
2018
Q1
$1.91M Buy
21,792
+14,850
+214% +$1.36M ﹤0.01% 1500
2017
Q4
$589K Buy
6,942
+5,582
+410% +$468K ﹤0.01% 2212
2017
Q3
$118K Sell
1,360
-5,769
-81% -$463K ﹤0.01% 3276
2017
Q2
$550K Buy
7,129
+6,929
+3,465% +$491K ﹤0.01% 2214
2017
Q1
$14K Sell
200
-26,294
-99% -$1.77M ﹤0.01% 3600
2016
Q4
$1.57M Buy
26,494
+26,250
+10,758% +$1.62M ﹤0.01% 1457
2016
Q3
$16K Hold
244
﹤0.01% 3603
2016
Q2
$13K Buy
244
+129
+112% +$7.07K ﹤0.01% 3595
2016
Q1
$6K Buy
115
+1
+0.9% +$52 ﹤0.01% 3755
2015
Q4
$8 Hold
114
﹤0.01% 3584
2015
Q3
$7 Buy
114
+33
+41% +$2.6K ﹤0.01% 3625
2015
Q2
$7 Buy
+81
New +$6.3K ﹤0.01% 3630

Other funds holding XBI

Manulife (Manufacturers Life Insurance)'s XBI Position: Q3 2025 in Review

Manulife (Manufacturers Life Insurance) sold out of State Street SPDR S&P Biotech ETF (XBI) in Q3 2025, closing a stake of 3,130 shares — an estimated $260K sold.

Manulife (Manufacturers Life Insurance) first reported a position in XBI in Q2 2015 and held it in 17 quarters. The position peaked at $6.64M in Q2 2020. 656 funds tracked by Wall St. Rank hold XBI as of Q3 2025.

  • Manulife (Manufacturers Life Insurance) reported no remaining State Street SPDR S&P Biotech ETF position as of Q3 2025 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 3,130 State Street SPDR S&P Biotech ETF shares in Q3 2025, an estimated $260K.
  • Manulife (Manufacturers Life Insurance) first reported a position in State Street SPDR S&P Biotech ETF in Q2 2015 and held it in 17 quarters.
  • Manulife (Manufacturers Life Insurance)'s State Street SPDR S&P Biotech ETF position peaked at $6.64M in Q2 2020.
  • 656 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2025.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q3 2025, filed 14 Nov 2025.